Baird Medical Investment Holdings Limited (BDMD)
NASDAQ: BDMD · Real-Time Price · USD
0.9204
+0.0157 (1.74%)
At close: Feb 6, 2026, 4:00 PM EST
0.9200
-0.0004 (-0.04%)
After-hours: Feb 6, 2026, 7:53 PM EST

BDMD Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
31.8637.0431.4635.0929.718.12
Revenue Growth (YoY)
-3.60%17.73%-10.35%18.16%63.92%48.37%
Cost of Revenue
4.164.384.237.055.032.51
Gross Profit
27.732.6527.2328.0424.6715.61
Selling, General & Admin
16.611.1611.0910.558.644.6
Research & Development
11.336.174.273.861.540.75
Other Operating Expenses
----0.310.19
Operating Expenses
27.9217.3415.3714.4110.075.94
Operating Income
-0.2215.3211.8613.6314.69.67
Interest Expense
-0.7-0.58-0.29-0.3-0.15-0.16
Interest & Investment Income
0000.0100
Currency Exchange Gain (Loss)
----0.05-
Other Non Operating Income (Expenses)
-0.52-0.650.781.18-0.98-3.77
EBT Excluding Unusual Items
-1.4414.0912.3614.5213.525.74
Other Unusual Items
----0.793.84
Pretax Income
-1.4414.0912.3614.5214.329.58
Income Tax Expense
1.571.491.71.752.532.43
Earnings From Continuing Operations
-3.0112.610.6612.7711.787.15
Minority Interest in Earnings
-0.17-0.14-0.11-0.21-0.1-0.05
Net Income
-3.1712.4510.5512.5711.687.1
Net Income to Common
-3.1712.4510.5512.5711.687.1
Net Income Growth
-18.09%-16.09%7.60%64.54%-
Shares Outstanding (Basic)
262626261,181-
Shares Outstanding (Diluted)
262626261,181-
Shares Change (YoY)
9.96%0.29%--97.84%--
EPS (Basic)
-0.120.490.410.490.01-
EPS (Diluted)
-0.120.490.410.490.01-
EPS Growth
-18.86%-16.33%4853.49%--
Free Cash Flow
-7.96-9.17-3.66-5.425.923.25
Free Cash Flow Per Share
-0.31-0.36-0.14-0.210.01-
Gross Margin
86.94%88.17%86.56%79.90%83.08%86.14%
Operating Margin
-0.70%41.35%37.71%38.85%49.16%53.38%
Profit Margin
-9.95%33.62%33.52%35.82%39.33%39.18%
Free Cash Flow Margin
-24.98%-24.75%-11.63%-15.46%19.95%17.94%
EBITDA
0.9216.4512.8814.5515.4210.28
EBITDA Margin
2.89%44.43%40.93%41.46%51.91%56.74%
D&A For EBITDA
1.141.141.010.920.820.61
EBIT
-0.2215.3211.8613.6314.69.67
EBIT Margin
-0.70%41.35%37.71%38.85%49.16%53.38%
Effective Tax Rate
-10.57%13.76%12.03%17.69%25.32%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q